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Optimal immunity to microorganisms depends upon
the regulated death of clonally expanded effector
cells and the survival of a cohort of cells that become
memory cells. After activation of naive T cells, CD44,
a widely expressed receptor for extracellular matrix
components, is upregulated. High expression of
CD44 remains on memory cells and despite its wide
usage as a ‘‘memory marker,’’ its function is
unknown. Here we report that CD44 was essential
for the generation of memory T helper 1 (Th1) cells
by promoting effector cell survival. This dependency
was not found in Th2, Th17, or CD8+ T cells despite
similar expression of CD44 and the absence of splice
variants in all subsets. CD44 limited Fas-mediated
death in Th1 cells and its ligation engaged the phos-
phoinositide 3-kinase-Akt kinase signaling pathway
that regulates cell survival. The difference in CD44-
regulated apoptosis resistance in T cell subpopula-
tions has important implications in a broad spectrum
of diseases.
INTRODUCTION
In becoming memory cells, T cells undergo stages of dramatic
expansion and contraction that depend upon regulated cell
death and thereafter are maintained by survival signals from
the environment. Survival of T cells during a response can be
profoundly affected by the availability of costimulatory mole-
cules and cytokines that modulate engagement of death
pathways (Krammer et al., 2007). Once a response subsides,
common gamma chain cytokines, such as interleukin-7 (IL-7)
and IL-15, are essential to the homeostatic control of T cell
memory (Boyman et al., 2007). However, as predominantly
mobile populations, both effector and memory T cells have the
potential to receive additional signals through adhesive interac-
tions with the extracellular matrix (ECM) or other cells (Gilmore,
2005). CD44 is an adhesion molecule that is expressed by
most cells and mediates binding to the ECM and other cells via
its only known in vivo ligand, the glycosaminoglycan hyaluronic
acid (HA) (Ponta et al., 2003). CD44 expression is upregulated
on naive T cells after activation via the T cell receptor (TCR)
and high expression is maintained indefinitely on memory cells104 Immunity 32, 104–115, January 29, 2010 ª2010 Elsevier Inc.(Pure´ and Cuff, 2001). As a consequence, elevated expression
of CD44 is generally used to identify antigen-experienced T cells.
CD44 is associated with cell migration and together with HA
has been implicated in numerous biological processes that are
regulated by migrating cells (Ponta et al., 2003). The function
of CD44 differs for different cell types and additional roles in
the regulation of proliferation and apoptosis have been
described (Hauptschein et al., 2005; Pure´ and Assoian, 2009).
CD44 is the product of a single gene that gives rise to a family
of HA-binding molecules by alternative exon RNA splicing
(Lynch, 2004). In addition to the nonvariant or standard form of
CD44, at least five isoforms are generated through translation
of various combinations of 10 variable exons, which are inserted
into a single site in themembrane proximal region of the extracel-
lular domain. Additional cell type-specific posttranslational
modifications of CD44 include differences in glycosylation
(Camp et al., 1991). The variable forms of CD44 contribute to
functional variations that allow for diverse interactions of cells
with their environments through a variety of signaling events,
which are not yet fully defined and can vary in different cell types
(Pure´ and Assoian, 2009).
Whereas CD44 has the potential to participate in several
processes associated with immune responses, the physiological
functions of CD44 in T cells in vivo remain ill defined. It has been
established that T cells bind HA, and that either HA binding or
TCR signaling can augment the adhesive function and expres-
sion of CD44 (DeGrendele et al., 1997; Lesley et al., 1994).
CD44 together with VLA-4 (a4 integrin) can regulate T cell migra-
tion into sites of inflammation (Nandi et al., 2004), and the
association of these receptors correlates with enhanced T cell
motility and survival after TCR stimulation in vitro (Marhaba
et al., 2006). The binding of CD44 expressed on T cells to HA
on the surface of dendritic cells (DCs) can promote cell clustering
(Do et al., 2004) that can be blocked by HA inhibitors (Mummert
et al., 2002). Although ligation of CD44 does not elicit prolifera-
tion of T cells, it can activate the TCR signaling-associated src
family kinases Lck and Fyn. This suggests that induction of
signaling events by CD44 impacts the T cell response (Rozsnyay,
1999), including that to TCR engagement (Fo¨ger et al., 2000).
CD44 has been associated with both resistance (Marhaba
et al., 2006; Naor et al., 2007; Wittig et al., 2000) and suscepti-
bility (McKallip et al., 2002; Nakano et al., 2007) of activated
T cells to apoptosis, suggesting that it participates in the control
of expansion. However, although CD44 is broadly connected
with the regulation of T cell responses, distinguishing direct roles
in vivo has remained elusive, prompting us to study its function in
CD4+ T cells.
Figure 1. Requirement for CD44 in the Generation of Memory Responses in CD4+ T Cells
CFSE-labeled OT-II cells from WT (Ly5.1) and Cd44 / (Thy1.1) mice were cotransferred (3 3 105 each) into C57BL/6 recipients (Ly5.2, Thy1.2) that were then
infected with WSN-OVAII. After 22 days, the recipients were challenged with HKx31-OVAII.
(A) The recovery of Tg+ WT and Cd44/ cells in the MSLN from individual animals.
(B) The percentage Tg+ cells in the Vb5+, CD4+ population from BAL, lung, MSLN, PLN, and spleen (mean ± SEM, n = 3–4/group).
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CD44 Regulates Survival and Memory in Th1 CellsBy using a murine model of influenza virus infection in which
a Th1 cell response is induced, we found that memory in CD4+
T cells failed to develop in the absence of CD44 engagement.
Although the development of effectors appeared to proceed nor-
mally without CD44, CD4+ T cells failed to survive because of
apoptosis that engaged caspase-8, suggesting the involvement
of extrinsic death-receptor signaling. Unexpectedly, Th1 cells,
but not Th2, Th17, or activated CD8+ T cells, showed a CD44
requirement for survival and resistance to apoptosis induced by
Fas-engagement in vitro,whichcorrelatedwithhigher expression
of Fas but not with differences in CD44. Further, ligation of CD44
in vivo enhanced Th1 cell accumulation and in vitro engaged the
Akt kinase signaling pathway, which can promote survival of acti-
vatedCD4+ T cells (Jones et al., 2002; Varadhachary et al., 2001).
Thus, CD44 maintained Th1 cells through active control, which
could be mediated by physical contacts with HA in the ECM or
on other cells. The results supported the concept that other
subsets of T cells were less susceptible to death in part because
of inherent differences in Fas expression (Varadhachary et al.,
1999; Zhang et al., 1997). This differential regulation may permit
strategies for immunotherapeutic targeting of Th1 cells in patho-
logical responses to infections and in autoimmune diseases.
RESULTS
Loss of CD4+ T Cell Memory in the Absence of CD44
To investigate the role of CD44 in the development of immunity,
we used an influenzamodel in which viral clearance from the lung
epithelium depends upon a local T cell response. In an initial
comparison of wild-type (WT) and CD44-deficient (Cd44/)
mice, we found that CD4+ and CD8+ lymphocyte subsets were
normally represented in Cd44/ mice, as previously reported
(Schmits et al., 1997), because of additional compensatory HA
binding receptors (Figure S1A available online; Naor et al.,
2007). Moreover, we did not find differences in expression of
several adhesion receptors, including CD62L, the integrins
CD11a and CD49, CD45RB, and CD69 on CD4+ T cells from
6-month-old animals (Figure S1B). Because CD44 is expressed
by multiple cell types, the role of CD44 in CD4+ T cells was
directly assessed with WT and Cd44/ mice crossed to OT-IITCR transgenic (Tg) mice whose CD4+ T cells recognize a
peptide of ovalbumin (OVAII or OVA323-339) (Barnden et al.,
1998). Naive WT and Cd44/ Tg CD4+ T cells marked by
expression of the Vb5 chain of the TCR and by the allelic variants
of Ly5.1 (CD45.1) or Thy1.1 (CD90.1), respectively, were isolated
by negative selection from the lymphoid tissues of 6-week-old
donors. The WT and Cd44/ cells were coinjected in equal
numbers into normal C57BL/6 mice (Thy1.2, Ly5.2) to provide
an internal control for the response. The cells were titrated to
the lowest number needed for a consistently detectable
response (3 3 105), where all cells became engaged as
measured by division that was detected by CFSE dilution. The
recipients were then infected with the William Smith Neurotropic
(WSN) influenza A virus (H1N1) expressing the OVAII peptide
(WSN-OVAII) (Chapman et al., 2005). CD4
+ T cell memory devel-
opment was assessed by challenging recipients 3 weeks later
with the recombinant influenza virus Hong Kong Aichi.2.68 x31
(H3N2) that also expressed the OVAII peptide (HKx31-OVAII)
(Thomas et al., 2006). The kinetics of cell expansion were
evaluated as measured by the recovery of donor cells.
At the time of challenge, the frequencies of donor cells were
very low. As anticipated, a memory response was observed
from WT OT-II donor cells in the draining mediastinal lymph
nodes (MSLN) as indicated by a >50-fold increase in the number
of Tg+ CD4+ T cells on day 4, the peak of the response
(Figure 1A). Dramatic increases in the frequencies of WT OT-II
cells were also observed in the airways (retrieved by bronchoal-
veolar lavage, BAL) and lungs, as well as other lymphoid tissues
(peripheral lymph nodes, PLN, and spleen) (Figure 1B). However,
CD4+ T cells from the Cd44/ OT-II donors were undetectable
in the MSLN (Figure 1A) and were present only in very low
numbers systemically (Figure 1B). The data suggest that expres-
sion of CD44 on CD4+ T cells might be necessary for either the
appropriate development of memory cells or their capacity for
expansion.
Unimpaired Induction of CD4+ T Cell Responses
in the Absence of CD44
CD44 can regulate T cell migration via interactions with vascular
endothelium through HA, which acts to initiate extravasation intoImmunity 32, 104–115, January 29, 2010 ª2010 Elsevier Inc. 105
Figure 2. CD44 Independence of CD4+ T Cell Priming
C57BL/6 mice were injected with CFSE-labeled WT and Cd44/
OT-II cells (1.5 3 106 each) and infected with WSN-OVAII.
(A) After 8 days, division of Tg+ cells was analyzed by CFSE. The
marker on each histogram shows the fraction of undivided cells.
(B) The average recoveries of Tg+ donor cells that underwent one or
more divisions on day 8 (mean ± SEM, n = 3–4/group).
(C) IFN-g and TNF-a production by WT and Cd44/ cells after over-
night restimulation by OVAII peptide with splenic APC.
(D) CFSE-labeled WT and Cd44/ OT-II cells were coinjected into
C57BL/6 recipients as for (A) together with 2 3 105 CD11c+, OVAII
peptide-pulsed DCs from either WT or Cd44/ C57BL/6 mice.
Recovery of donor CD4+ T cells that had undergone one or more
divisions in the spleen 4 days later (mean ± SEM, n = 4/group).
(E) WT OT-II Th1 cells were generated with APC and OVAII peptide in
the presence of the blocking anti-CD44 mAb, KM201, or control IgG.
The cells were then injected into separate groups of C57BL/6 recipi-
ents (2 3 106/mouse). The donor Tg+ cells recovered in the pooled
lymph node (LN) and spleens of mice are shown at the indicated times
after injection (mean ± SEM, n = 3–4/group).
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CD44 Regulates Survival and Memory in Th1 Cellstissue (DeGrendele et al., 1997; Nandi et al., 2004). Therefore,
the absence of CD44 could generally affect the trafficking of
Cd44/ CD4+ T cells. Thus, we evaluated the recovery of naive
Cd44/ andWTCD4+ T cells with time after transfer to unimmu-
nized hosts. The presence of comparable numbers of naive and
WT cells (Figure S2A) in the lymphoid compartment and no
differences in their distribution (data not shown) suggest normal
homeostatic regulation and migration. Because inflammation
could affect CD4+ T cell trafficking and because cells from
Cd44/ mice display the normal responses to TCR activation
in vitro (Schmits et al., 1997), we tested whether the failure of
Cd44/ CD4+ T cells to generate a memory effector population
could be attributed to defects in trafficking of naive or effector
cells after influenza virus infection. Homing of naive or in vitro-
activated OT-II effector CD4+ T cells to either lymphoid or
nonlymphoid tissues was unimpaired by the absence of CD44
irrespective of whether the recipients were naive or were
infected several days previously (Figures S2B and S2C). Thus,
although CD44 can regulate homing of CD4+ T cells106 Immunity 32, 104–115, January 29, 2010 ª2010 Elsevier Inc.(DeGrendele et al., 1997), this function is not essential
and/or is replaceable by other adhesion receptors.
Although differences in the responses of Cd44/ and
WT OT-II cells to TCR stimulation with peptide and
antigen-presenting cells (APCs) were not observed
in vitro, it is possible that CD44 contributes to the initial
priming or responses of CD4+ T cells in vivo. Therefore,
the division of adoptively transferred WT and Cd44/
Tg+ cells was analyzed by CFSE dilution at the peak of
the response to WSN-OVAII. Here we used a higher
dose of Tg+ cells to observe potential differences in the
kinetics of division. Similar kinetics of division in WT and
Cd44/ cells (Figure 2A) and distribution of cells in the
lymphoid tissues and lungs as measured by recovery
(Figure 2B) were observed. This suggests that CD44 is
not essential for either the induction of a CD4+ T cell
response to influenza virus or for the migration of CD4+
T cells. Furthermore, both populations exhibited a similar
capacity to develop effector function as measured bysecretion of IFN-g and TNF-a (Figure 2C). Additionally, we
directly confirmed that expression of CD44 was not required
on either CD4+ T cells or DCs to initiate a primary response
in vivo, as shown by the induction of comparable numbers of
dividing WT and Cd44/ cells after immunization with OVA
peptide-pulsed WT or Cd44/ splenic DCs (Figure 2D). To
further investigate whether blocking CD44 during Th1 cell
priming could predispose the cells to death, OT-II cells were
treated with the CD44 adhesion-blocking mAb, KM201 (Zheng
et al., 1995), during in vitro culture with APCs and peptide under
Th1 cell polarizing conditions. Cell recoveries at day 4 were
similar to the isotype control-treated cultures, and exposure to
KM201 did not negatively affect the ability of Th1 cells to persist
(Figure 2E). The results show that initial activation, expansion,
and effector development proceed normally in Cd44/ CD4+
T cells.
These findings suggest that the mechanisms which limit the
development of memory in CD4+ T cells could become manifest
at the later stages of the primary response. Therefore, cell
Figure 3. Loss of CD4+ T Cell Effectors in the Absence of CD44 Engagement
C57BL/6 recipients were injected with CFSE-labeled WT and Cd44/ OT-II cells (1.5 3 106 each) and infected with WSN-OVAII.
(A and B) On day 13 after infection, division (A) and recovery (B) of Tg+ cells was determined as for Figure 2 in the MSLN and spleen.
(C and D) Recipients of CFSE-labeled WT OT-II cells were injected with either KM201 anti-CD44 or control IgG at the time of cell transfer and infection with
WSN-OVAII influenza virus and three more times at 3 day intervals.
(C) The division of the donor cells on days 6 and 13.
(D) Recovery of donor CD4+ T cells that had undergone one or more divisions in the MSLN and spleen 8 and 13 days after infection.
(E and F) WT and Cd44/ mice were infected with PR8 influenza virus.
(E) The mice were treated with BrdU for 7 days before sampling. The recovery of BrdU+ CD4+ T cells is shown.
(F) On day 21 after infection, the virus-specific CD4+ T cell response was assessed by intracellular staining of cells from the lungs and BALs after overnight culture
with anti-CD28 in the presence or absence of NP311 peptide. Shown are the percentages of CD154
+IFN-g+ virus-specific CD4+ T cells in the lung.
(B, D–F) Mean + SEM, n = 3–4/group.
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CD44 Regulates Survival and Memory in Th1 Cellsdivision was analyzed at 13 days after infection. DividedCd44/
CD4+ T cells failed to accumulate in the lymphoid tissues and
were not detected in the lungs (Figures 3A and 3B). In order to
prevent ligand binding by CD44, the KM201 mAb was adminis-
tered, beginning at the time of WT cell transfer and infection.
This did not affect the recovery of divided cells on day 6, but
the accumulation of responding CD4+ T cells on day 13 wasinhibited when compared to mice that received control IgG
(Figures 3C and 3D). This outcome is unlikely to be due to
cytotoxic effects, because KM201 and several other anti-CD44
reagents did not elicit complement-mediated killing of activated
OT-II cells (data not shown). The results suggest that CD44
participates in mechanisms that promote the survival of acti-
vated CD4+ T cells.Immunity 32, 104–115, January 29, 2010 ª2010 Elsevier Inc. 107
Figure 4. Induction of Apoptosis in Responding CD4+ T Cells Deficient in CD44
C57BL/6 recipients were given WT and Cd44/ OT-II cells (1.5 3 106 each) and infected with WSN-OVAII.
(A) Apoptosis was assessed by binding of Annexin V and exclusion of 7AAD byWT Tg+ cells (shaded histograms) and Cd44/ Tg+ cells (open histograms) in the
indicated tissues.
(B) Viable recoveries of WT and Cd44/ donor Tg+ cells in the MSLN and lungs (mean ± SEM, n = 5/group).
(C) Caspase 8 activation was assessed with a fluorophore-modified substrate in dispersed MSLN cells from recipients of WT and Cd44/ CD4+ T cells on day 7
after infection. The fluorescence induced by activated caspase 8 for WT Tg+ cells (shaded histogram) and Cd44/ Tg+ cells (open histogram) is shown in 7AAD
Tg+ population. The results are representative of those from six recipients.
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CD44 Regulates Survival and Memory in Th1 CellsBecause the model used involves transfer of a relatively large
number of Tg+ CD4+ T cells that might affect regulation, the
responses of endogenous CD4+ T cells from the lungs and
MSLN of WT and Cd44/ mice were assessed (Schmits et al.,
1997) after infection with influenza virus with BrdU uptake
(Figure 3E). The results showed that fewer divided CD4+ T cells
were present in the MSLN of Cd44/ mice compared to WT
mice on day 14. In addition, the lungs and BAL contained fewer
virus-specificCd44/CD4+ T cells thanWTCD4+ T cells on day
21 (Figure 3F).
Responding Cd44/ CD4+ T Cells Die by Apoptosis
To assess whether apoptosis was evident in Cd44/ CD4+
T cells during expansion after infection, Annexin V binding was
examined in cells from the MSLN and lungs (Figure 4A).
Apoptotic cells were observed on day 8, followed by the disap-
pearance of responding cells on day 9 (Figure 4B). Because
CD44 has been associated with resistance to Fas-mediated
cell death in various cell lines and tumor cells (Hauptschein
et al., 2005; Mielgo et al., 2006), the activation of intracellular
caspase 8 in Cd44/ CD4+ T cells was quantified. Activation
characterizes the induction of extrinsic apoptotic death (Kim
et al., 2006) and occurs as a consequence of the assembly of
the death-inducing signaling complex (DISC). On day 7 after
adoptive transfer, activated caspase 8 was markedly increased
in Cd44/ cells compared to WT cells from the MSLN (Fig-
ure 4C). Although changes in Bcl-2 family members correlate
with the loss of CD44 and cell death in various cell types
in vitro (Marhaba et al., 2003), no altered expression of the proa-
poptotic members Bim and BNIP-3 or the antiapoptotic108 Immunity 32, 104–115, January 29, 2010 ª2010 Elsevier Inc.members Bcl-2 and Bcl-xl was detected (Figure S3). The results
support the hypothesis that death receptors participate in the
mechanism of Cd44/ CD4+ T cell death in vivo and suggest
a previously unidentified role of CD44 in maintaining CD4+
effector T cells engaged in an immune response.
CD44 Can Regulate CD4+ T Cell Survival in the Absence
of Antigen
After influenza virus infection, antigen presentation to CD4+
T cells is prolonged (Jelley-Gibbs et al., 2005), raising the possi-
bility that TCR-mediated activation-induced cell death (AICD)
occurs in the absence of CD44. We therefore asked whether
death of Cd44/ CD4+ T cells occurred in the absence of overt
signaling by antigen. To this end, activated effectors were gener-
ated from WT and Cd44/ OT-II cells in culture. Both popula-
tions underwent comparable expansion and were similarly acti-
vated as measured by size (data not shown). Although WT and
Cd44/ effector cells showed similar distribution 1 day after co-
injection into normal recipients, Cd44/ CD4+ T cells decayed
more quickly than WT cells in the lungs and spleen (Figure 5A),
as well as in the PLN, liver, and bone marrow (data not shown).
To confirm that impaired survival was not unique to Tg+ cells or
the viral response, we examined the decay of Cd44/ effector
CD4+ T cells that were generated from polyclonal naive cells
in vitro. Decay of Cd44/ CD4+ T cells compared to WT cells
was pronounced (Figure 5B). The results support the concept
that activated CD4+ T cells that are unable to engage CD44
ligands fail to survive in the absence of CD44.
Because CD4+ T cells develop into distinct subsets specified
by different transcription factors and signature cytokines
Figure 5. Impaired Survival of Activated CD4+ T Cells in Naive Recipients in the Absence of CD44
(A) WT and Cd44/ OT-II cells were stimulated in vitro with APC and OVA peptide and then coinjected (1.5 3 106 each) into naive C57BL6 recipients.
The frequencies of Tg+ cells, gated on the Vb5+, CD4+ population in the lungs and spleen at the indicated times after cell transfer, are shown (mean ± SEM,
n = 4/group).
(B) Polyclonal, non-Tg WT CD4+ T cells (Thy1.1, Ly5.2) and Cd44/ CD4+ T cells (Thy1.2, Ly5.2) were stimulated with anti-CD3/anti-CD28 and coinjected into
Ly5.1, Thy1.2 recipients in a dose of 1.5 3 106/recipient. The recovery of donor cells in the spleen is shown (mean ± SEM, n = 4/group).
(C) Th1, Th2, and Th17 cells were generated from OT-II cells with APC and OVAII peptide. Allelically marked WT and Cd44
/ cells of each of the corresponding
subsets were coinjected in a dose of 1.53 106 each into C57BL/6 recipients. Shown are the frequencies of donor cells recovered at the indicated times after cell
transfer after gating on the Vb5+, CD4+ population.
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CD44 Regulates Survival and Memory in Th1 Cells(Harrington et al., 2006), and the response to influenza virus is
Th1 cell biased, we next asked whether the polarization of
CD4+ effector T cells might affect CD44-dependent regulation
of apoptosis. Th1, Th2, and Th17 WT and Cd44/ cells were
generated from naive CD4+ T cells with the appropriate cyto-
kines. The effector phenotypes were confirmed by cytokine
analysis with production of IFN-g and TNF-a by Th1 cells,
IL-17 by Th17 cells, and IL-4 and IL-10 by Th2 cells (Figure S4A).
The CD4+ T cell subpopulations were similarly activated as
indicated by the expression of CD11a and CD69 (Figure S4B).
WT and Cd44/ effectors of each subset were coinjected into
C57BL/6 recipients. The donor cell recoveries at days 1, 7, and
14 revealed that only Th1 cells were affected by the absence
of CD44 (Figure 5C). With Th1 and Th2 WT and Cd44/ cells,
no differences were observed in their ability to home to lymphoid
tissues (Figure S4C) or to localize in the T cell areas of the
spleens (Figure S4D). To determine whether CD44 might play
a role in the survival of CD8+ T cells, TCR Tg+ OVA-specific
OT-I or polyclonal CD8 effectors were generated from WT and
Cd44/ mice. In contrast to Th1 cells, the decay of CD8+
T cells in unimmunized recipients was not altered by the absence
of CD44 (Figure S5). Thus, CD44 regulates CD4+ Th1 cellsdistinctly and plays a nonredundant role in the regulation of the
Th1 cell response and ultimately their development into memory
cells.
CD44 Limits Fas-Induced Death in Th1 Cells
The differential requirements of the CD4+ T cell subsets could
not be attributed to CD44 expression, because this was equal
between Th1 and Th2 cells (Figure 6A). Previous studies
established that Th1 cells differ from Th2 cells with respect to
regulation of apoptosis (Hur et al., 2007; Toscano et al., 2007;
Zhang et al., 1997) and differential expression of CD44 isoforms
has previously been associated with protection against death of
various cell lines, including T cell lines (Mielgo et al., 2006).
However, no splice variants were observed in Th1 and Th2 cells;
only the standard form of CD44 was detected (Figure 6B;
Figure S6A). In addition, no major differences in glycosylation
that would lead to differences in the sizes of CD44 on Th1 versus
Th2 cells were observed (Figure S6B).
CD44 has been associated with regulation of Fas (CD95)-
mediated cell death (Hauptschein et al., 2005; Mielgo et al.,
2006). We therefore compared expression of Fas and CD44 on
Th1 and Th2 cells. Th1 cells expressed much higher amountsImmunity 32, 104–115, January 29, 2010 ª2010 Elsevier Inc. 109
Figure 6. CD44s Regulates Fas-Mediated Death in Th1 Cells
(A) Th1 and Th2 cells were generated from WT and Cd44/ OT-II Thy1.1 cells with OVAII peptide and APC and tested for expression of CD44.
(B) Th1, Th2, and Th17 cells were generated fromWT and Cd44/OT-II cells. RNA was isolated and tested for the presence of CD44 splice variants by RT-PCR
with primers for the constant regions that flank the variant region. CD44 standard is 428 bp in size.
(C) Expression of Fas (CD95) on Th1 and Th2 cells.
(D) Th1, Th2, and Th17 cells were generated from WT and Cd44/ CD4+ T cells and recultured overnight in the presence or absence of plate-bound Fas mAb.
The number after the colored bars indicate the percentages of cells undergoing apoptosis as indicated by binding of Annexin V and exclusion of 7AAD.
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CD44 Regulates Survival and Memory in Th1 Cellsof Fas than Th2 cells, a difference that was also evident with
Cd44/ Th1 and Th2 cells (Figure 6C). Furthermore, incubation
of in vitro-polarized CD4+ T cells with anti-Fas elicited apoptosis
in Cd44/ Th1 cells, but not Th2 or Th17 cells (Figure 6D). This
difference in Th1 cell susceptibility to apoptosis was detectable
by 3 hr after Fas ligation (Figure S6C). Thus, CD44 and Fas could
interact to limit death of Th1 cells by affecting extrinsic death
receptor engagement or signaling. However, we were unable
to detect a physical association of these molecules in the
membranes of Th1, Th2, or Th17 cells by immunoprecipitation
or fluorescence microscopy (data not shown).
CD44 Regulates Th1 Cell Survival by Engaging
the PI3K-Akt Signaling Pathway
We next sought to determine whether signals that might
contribute to CD4+ T cell survival could be initiated by CD44.
Therefore, we examined the recoveries of Th1 effector cells after
transfer to unimmunized recipients that were treated with the
agonist CD44 agonist antibody, IRAWB 14 (Lesley et al., 1993)
or with the CD44 blocking antibody KM201. Compared to the
IgG control, greater or reduced persistence of Th1 cells was110 Immunity 32, 104–115, January 29, 2010 ª2010 Elsevier Inc.observed after treatment with IRAWB 14 or KM201, respectively
(Figure 7A). Thus, for Th1 cells, blocking CD44 binding to its
ligand(s) inhibits survival, whereas signaling through CD44
enhances survival, implying a direct effect of CD44 engagement.
To test this prediction in an immune response, mice were
treated with IRAWB 14 or control IgG at the time of transfer of
WT OT-II cells and infection with the influenza virus. After IRAWB
14 treatment, there was a greater recovery of CD4+ T cells
engaged in the response by division as compared to the controls
on day 13 after infection (Figure 7B). The results suggest that
ligation of CD44 can promote the accumulation of CD4+ T cells
either by effects on survival, expansion, or both. However,
IRAWB 14 did not promote proliferation of in vitro activated WT
OT-II cells (data not shown), and other studies support the
concept that ligation of CD44 without TCR signaling does not
promote division of T cells (Marhaba et al., 2006). Thus, the
data suggest that CD44 participates in maintaining survival of
effector cells engaged in the response to influenza virus. To
determine whether CD44 was required during the expansion
versus contraction phase of the CD4+ T cell response to influ-
enza virus, IRAWB 14 or control Ig treatment was initiated on
Figure 7. Requirement for CD44 Signaling in Th1 Cells
(A) WT OT-II Th1 cells were generated with APC and OVAII peptide. The cells were then injected into C57BL/6 recipients (1.5 3 10
6/mouse) and treated with
control IgG, KM201, or IRAWB 14 on the day of cell transfer, and three more times at 3 day intervals. The donor Tg+ cells recovered in the pooled LN and spleens
are shown at the indicated times after injection.
(B) C57BL/6 recipients of 1.53 106 CFSE-labeled WT OT-II cells were injected with either IRAWB 14 or control IgG at the time of cell transfer and infection with
WSN-OVAII influenza virus. The antibodies were administered threemore times at 3 day intervals. The recoveries of donor CD4
+ T cells that had undergone one or
more divisions in the MSLN and spleen were measured 8 and 13 days later.
(C) C57BL/6 recipients of 1.53 106CFSE-labeledWTOT-II cells were injectedwith either IRAWB14 or control IgG 8 days after infectionwithWSN-OVAII influenza
virus. The recoveries of donor CD4+ T cells that had undergone one or more divisions in the MSLN and spleen were measured at 10 days after infection.
(A–C) Mean ± SEM, n = 3–4/group.
(D and E) Th1 and Th2 cells were generated fromWT andCd44/C57BL/6CD4+ T cells by stimulation with plate-bound anti-CD3 and anti-CD28. After resting for
1 day in rIL-7 and a further day without, the cells were cultured for the indicated times with plate-bound IRAWB 14 mAb.
(D) Phospho-Akt was detected by immunoblot and compared to the p85 subunit of PI3K as a loading control.
(E) Densitometry of phospho Akt on immunoblot data in (C). Results are represented as a ratio between band densities for IRAWB 14 and unstimulated control
cells and are corrected for loading differences.
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animals. No differences in the recoveries of OT-II cells were
observed under these conditions on day 10 of the response
(Figure 7C). These data imply that CD44-regulated survival
signals are engaged during CD4+ T cell expansion.
Ligation of CD44 can lead to activation of the PI3K-Akt
pathway in some cell types (Klingbeil et al., 2009) and can inhibit
Fas-mediated CD4+ T cell death (Varadhachary et al., 2001) by
interfering with DISC assembly (Jones et al., 2002). To determine
whether ligation of CD44 might differentially signal in T cell
subsets, Th1 and Th2 cells were generated from WT OT-II cells.
After resting for 2 days, the cells were cultured with plate-boundIRAWB 14 or with the control IgG antibody. Phosphorylated Akt
was measured as a downstream readout of PI3K activation.
Phosphorylated Akt was induced in Th1 cells with peak expres-
sion of 30 min after ligation of CD44, whereas this response was
lower in Th2 cells and was not observed until 60 min (Figures 7D
and 7E). To confirm the CD44 dependence of PI3K induction, Akt
phosphorylation in WT Th1 cells was compared to Cd44/ Th1
cells in response to IRAWB 14. PI3K was engaged only in theWT
Th1 cells and expression could be reduced with the PI3K inhib-
itor Ly294002 (Figure S7). The results support the concept that
CD44 engagement elicits signaling that promotes survival in
Th1 cells, which may be crucial in this subset because of theImmunity 32, 104–115, January 29, 2010 ª2010 Elsevier Inc. 111
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to apoptosis by this pathway.
DISCUSSION
In this study, we identified a critical function of CD44 in the regu-
lation of memory generation in Th1 CD4+ T cells. Despite poten-
tial roles in migration and interactions with DCs, CD44 was not
required for the initial induction of a primary immune responses
in vivo or for the localization of naive or effector cells in either
lymphoid or nonlymphoid tissues. This is probably because of
redundancies in adhesion receptor usage that enable T cells to
bypass its contribution and/or the ability of other HA binding
receptors to perform these functions. However, CD44 plays a
nonredundant role in regulating the survival of CD4+ effector
T cells in the influenza model, which is dominated by a Th1 cell
response. Without engagement of CD44, effector cells that
have progressed through several rounds of division died by
apoptosis, whereas agonist signaling via CD44 during the
expansion phase led to enhanced in vivo accumulation of
effector cells. Thus, the generation of a memory population in
Th1 cells most probably depends upon engagement of CD44
on responding effectors during the primary response. We
showed that CD44 ligation activated the PI3K-Akt signaling
pathway in Th1 cells. The mechanism by which CD44 activates
PI3K remains to be explored, but could be due to constitutive
association with the src family kinases Lck and Fyn (Rozsnyay,
1999) or to associations with b1 integrins that mediate the
survival response (Lee et al., 2008; Marhaba et al., 2006; Nandi
et al., 2004).
Th1 cells may uniquely require this survival signal through
CD44 because of elevated Fas expression and an inherent ability
to rapidly assemble the DISC in response to Fas trimerization
(Varadhachary et al., 1999). Thus, we suggest that without
engagement of CD44, the response to Fas ligation cannot be
overcome. Such a mechanism may not be necessary in Th2
cells, and possibly other subsets of T cells, because of overall
lower expression of Fas in addition to a greater capacity to
engage PI3K-Akt in response to TCR signaling or costimulation
(Varadhachary et al., 1999). It is of significance that activation
of PI3K-Akt can block DISC formation by preventing the
association of FADD and recruitment of pro-caspase 8 in CD4+
T cells (Jones et al., 2002), and our studies lead us to favor this
mechanism for regulation of Th1 cell survival.
Although CD44 can mediate resistance of tumor cells to
apoptosis by death receptor ligation via FasL-Fas, DR5-TRAIL,
and TNFR1-TNF-a by interfering with DISC assembly through
the physical association of Fas and CD44 (Hauptschein et al.,
2005), this interaction occurs through variant isoforms. Isoforms
that include variants v6 and v9 are in close proximity with Fas in
the membranes of transfected Jurkat cells and thereby prevent
Fas trimerization (Mielgo et al., 2006). However, the lack of
CD44 isoforms on CD4+ T cells activated in vivo after influenza
virus infection (data not shown) or on Th1, Th2, or Th17 cells
generated in vitro, which differ in their susceptibility to Fas-medi-
ated death in the absence of CD44, further argues against
sequestration of Fas as the only mechanism that accounts
for a selective function of CD44 in Th1 cells. The lack of CD44
isoforms on CD4+ T cell subsets also argues against a mecha-112 Immunity 32, 104–115, January 29, 2010 ª2010 Elsevier Inc.nism whereby osteopontin binding to CD44 variants containing
v7 leads to activation of NF-kBand preventsmitochondrial death
controlled by the transcription factor Foxo3a, a regulator of Bim
(Hur et al., 2007). Indeed, we did not detect changes of either
pro- or antiapoptotic Bcl-2 family proteins in WT compared to
Cd44/ CD4+ T cells. Although differences in glycosylation of
Th2 cells have been reported to account for resistance to cell
death compared to Th1 and Th17 cells (Toscano et al., 2007),
the mechanism involves protection from binding of galectin-1,
and we did not observe differences in the molecular weight of
CD44 from Th1 and Th2 cells that would suggest significant
differences in glycosylation. Because CD44 is upregulated on
activated and memory CD8 cells, we did not anticipate differ-
ences in their regulation that would suggest independence
from CD44-mediated survival signals. However, there are
many differences in the regulation of CD4+ and CD8+ T cells,
including in the programming to develop into memory cells after
the initiation of a response (Kaech and Ahmed, 2001; van Stip-
donk et al., 2003). Our data support the concept that internal
signaling differences rather than external molecular variations
account for the differences in regulation by CD44 on T cells.
A role for CD44 in regulating survival of CD4+ T cells engaged
in an immune response in vivo has not been previously examined
directly. However, protection from TCR-mediated AICD byCD44
has been suggested by in vitro studies of in vivo primed cells
(Marhaba et al., 2003). The results described herein, which
show normal priming of CD4+ T cells in vivo irrespective of the
presence of CD44 on T cells or DCs, support the concept that
engagement of CD44 in vivo is required for Th1 cells only after
activation. Our results suggest that survival signals are trans-
mitted in Th1 cells during the expansion phase of the effector
response to influenza virus, which is profoundly compromised
in the absence of CD44 or when adhesion binding of CD44 is
blocked.
A CD44-dependent survival mechanism remained operative in
activated Th1 cells that were withdrawn from overt Ag stimula-
tion by transfer into naive recipients. This result suggests that
TCR signaling in the context of an effector response and the
production of proinflammatory cytokines, both of which can
augment CD44 binding of HA (Marhaba et al., 2003), are not
necessary for the function of CD44 in promoting apoptosis resis-
tance. Indeed, in the absence of an immune response, agonist
engagement of CD44 in vivo promoted enhanced accumulation
of CD4+ T cells. Our previous studies indicate that maintaining
effector survival through costimulation can be key to the gener-
ation of robust memory in CD4+ T cells (Linton et al., 2000, 2003).
In this regard, we propose that CD44 can be viewed as an
ECM-dependent, Th1 cell-specific ‘‘costimulatory’’ molecule
that sustains effector cell responses through survival and
thereby supports the development of memory.
The homeostasis of many cell types is regulated by contact
dependence, and signals from the ECM can be crucial to prevent
cells from undergoing anoikis or programmed cell death, which
can be due to intrinsic death resulting in mitochondrial permea-
bilization, and extrinsic death that is initiated by death receptors
(Gilmore, 2005). Although themolecular mechanisms that lead to
PI3K activation and the downstream targets in Th1 cells remain
to be defined, our results support the concept that physical
contacts of Th1 cells with HA in the immediate environment
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signals are engaged. By promoting optimal survival of effector
CD4+ T cells engaged in an immune response (clonal burst),
CD44 provides a previously unknown contribution to the devel-
opment of T cell immunity in vivo.
EXPERIMENTAL PROCEDURES
Mice and Viruses
Cd44/mice (Schmits et al., 1997) were bred to B6PL-Thy mice and crossed
to OT-I and OT-II TCR Tg mice in the vivarium at the Burnham Institute
for Medical Research. These mice were also crossed to B6 Ly5.1 mice.
C57BL/6 mice were purchased from Jackson Laboratories. All mice were
males between 6 and 16 weeks of age. The mice were housed under specific
pathogen-free conditions according to NIH guidelines. The use of the animals
for the experiments described herein was approved by the IACUC review
committee at the Burnham Institute.
All influenza viruses were grown in chicken eggs (10 days of embryonation)
and titrated with MDCK cells for plaque-forming units (pfu) (Jelley-Gibbs et al.,
2005). Infective doses elicited an optimal T cell response and were given i.n. in
30 ml. The WT influenza A viruses Puerto Rico/8/34 (PR8, H1N1) was given
in a dose of 12.5 pfu. The engineered influenza A viruses William Smith
Neurotropic/33 (WSN-OVAII, H1N1) (Chapman et al., 2005) and Hong Kong
Aichi/2/68 (HKx31-OVAII, H3N2) (Thomas et al., 2006) that express the
OVA323-339 peptide recognized by OT-II CD4
+ T cells were given in doses of
1250 pfu and 112 pfu, respectively.
Antibodies for Cell Surface and Intracellular Proteins
Anti-Thy1.1 (CD90.1, OX-7) and -Ly5.1 (CD45.1, A20) were from BioLegend.
The following antibodies were from eBioscience: Bcl2 (10C4), Bcl-xl (2H12),
and Bnip3 (polyclonal rabbit), IFN-g (XMG1.2) and TNF-a (MP6xt22). Anti-
vb5 (MR9) and anti-Fas (CD95, Jo2) were from BD Biosciences. Anti-BimS
(14A8) was from Millipore. Cell lines producing the adhesion blocking
anti-CD44 mAb, KM201, and the agonist/activating anti-CD44 mAb, IRAWB
14, were obtained from P. Kincade (Zheng et al., 1995). These mAb, anti-CD3
(145-2C11), and anti-CD28 (37.51) were produced and purified by BioLegend.
Rat IgG was used as the control (Jackson ImmunoResearch).
Cell Preparation
CD4+ and CD8+ T cells were isolated from pooled spleen and lymph nodes
by magnetic sorting (Imag, BD Biosciences) according to the manufacturer’s
protocol. To generate effector cells, naive T cells were cultured at 106/ml for 4
days with immobilized anti-CD3 (10 mg/ml) and anti-CD28 (5 mg/ml) and from
TCR Tg mice with C57BL/6 splenic APCs (2 3 106/ml), and 5 mM OVA
peptides (257-264, OT-I and 323-339, OT-II, Sigma-Genosys) (Harbertson
et al., 2002). CD4+ T subsets were polarized in the presence of rIL-2
(10 ng/ml) with anti-CD3 and anti-CD28, or with APCs and peptide for
4 days. Th1 cells were elicited with rIL-12 (5 ng/ml), and anti-IL-4 (11b11,
10 mg/ml) and Th2 cells with rIL-4 (10 ng/ml) and anti-IFN-g (XMG1.2,
10 mg/ml). For Th17 cells, we used rIL-1b (10 ng/ml), rIL-6 (20 ng/ml), rTGF-b1
(1 ng/ml), TNF-a (10 ng/ml), and 10 mg/ml each of anti-IL-4 and anti-IFN-g.
Splenic DCs were enriched by centrifugation with 13.5% (w/v) histodenz
(Sigma) (McLellan et al., 1995).
Adoptive Transfer and Detection of T Cells
T cells were injected i.v. into recipients in doses of 0.3–3.0 3 106 with donor
and host combinations that differed by expression of Thy1 or Ly5. WT and
Cd44/ cells were coinjected in equal ratios. DCs pulsed for 2 hr with
10 mg/ml OVA peptide were injected in a dose of 1 3 105/recipient at the
time of T cell transfer. After sacrifice, cells in the airways of recipient mice
were collected by BAL. Cell suspensions of perfused lungs were obtained
by digestion with collagenase D (Roche) at 10 mg/ml for 60 min at 37C.
Flow cytometry was used to detect Tg+ CD4+ T cells in these tissues, and in
LN and spleen cells after fluorescent staining for CD4, Thy1.1, Ly5.1, and
vb5 (BD Biosciences). Viable lymphocyte recovery was determined by flow
cytometry with propidium iodide uptake.T Cell Responses
CFSE or BrdU labeling (Harbertson et al., 2002; Linton et al., 2003) were used
to assess cell division. Intracellular staining was used to detect cytokine
secretion by donor cells after overnight culture of lymphocyte suspensions
from the MSLN with splenic APC and OVAII peptide (Harbertson et al., 2002;
Linton et al., 2003). After surface staining, the cells were permeabilized
(BD Biosciences) and stained with anti-IFN-g and -TNF-a. Annexin V and
7-Amino-actinomycin D (7AAD) staining were used to distinguish dead from
dying cells by flow cytometry. To test caspase 8 activity, freshly isolated
MSLN cells were incubated with CaspaLux 8-L1D2 (OncoImmunin, Inc)
according to the manufacturer’s protocol. Fas-mediated cell death was
induced with plate-bound anti-Fas (10 mg/ml). In vitro treatment of CD4+
T cells with anti-CD44 mAb or Rat IgG was done as soluble or plate bound
(10 mg/ml) as indicated in the text.
Anti-CD44 Treatment In Vivo
KM201, IRAWB 14, or Rat IgG were administered in a dose of 200 mg/mouse
on the day of cell transfer and three times thereafter spaced by 3 day intervals
or given in a dose of 1 mg/mouse 8 days after cell transfer.
PCR for CD44 Isoforms
OTII CD4+ T cells were enriched and polarized as described above and RNA
isolated (RNeasy, QIAGEN). Primers spanning the CD44 isoform region
(forward Exon 5 primer: CATCAGTCACAGACCTACCCAATTCC and reverse
exon 16 primer CCAAGATGATGAGCCATTCTGGAATC) (Figure S6A) were
used to distinguish isoforms by RT-PCR (GeneAmp, Applied Biosystems).
Reverse transcriptase was for 60 min at 42C via random hexamers and
reverse primer, followed by PCR with the following conditions: 94C 2 min,
64C 30 s, 72C 1 min 30 s (35 cycles).
Immunoblots for Akt
CD4+ cells from WT or Cd44/ mice were stimulated with plate-bound
anti-CD3 plus anti-CD28 (5 mg/ml each) under Th1 or Th2 cell conditions for
4 days (see above), followed by 2 days of resting in RPMI culture medium
with or without rIL-7 for the first 24 hr. To crosslink CD44, 106 cells were plated
on IRAWB 14- or rat IgG-coated plates, incubated at 37C for 15, 30, 60, or
120 min. After stimulation, cell lysate proteins were resolved through 4%–
12% PAGE and transferred to nitrocellulose membranes. The membranes
were probed and reprobed with Abs to phospho-Akt and p85 subunit
of PI3K (Cell Signaling Technology), respectively. Densitometry on blots was
performed with ImageJ (NIH).
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